(Q34720353)

4 August 2017

1 reference

title

Pharmacotoxicological aspects of levosulpiride (English)

1 reference

4 August 2017

F. Rossi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7596959

3 June 2024

A. Forgione

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7596959

3 June 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7596959

3 June 2024

publication date

1 February 1995

1 reference

full work available at URL

4 August 2017

https://api.elsevier.com/content/article/PII:1043661895800522?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/1043-6618(95)80052-2

https://api.elsevier.com/content/article/PII:1043661895800522?httpAccept=text/plain

3 June 2024

1 reference

https://api.crossref.org/works/10.1016/1043-6618(95)80052-2

3 June 2024

published in

Pharmacological Research

1 reference

4 August 2017

volume

31

1 reference

4 August 2017

issue

2

1 reference

4 August 2017

page(s)

81-94

1 reference

Advances in biochemical psychopharmacology

4 August 2017

cites work

4

35

109

Jenner

1982

1 reference

https://api.crossref.org/works/10.1016/1043-6618(95)80052-2

The neurobiologically active benzamides and related compounds: some historical aspects

3 June 2024

6

1 reference

https://api.crossref.org/works/10.1016/1043-6618(95)80052-2

The pharmacology of sulpiride--a dopamine receptor antagonist

3 June 2024

8

1 reference

https://api.crossref.org/works/10.1016/1043-6618(95)80052-2

Multiple Dopamine Receptors in Brain and the Pharmacological Action of Substituted Benzamide Drugs

3 June 2024

11

1 reference

https://api.crossref.org/works/10.1016/1043-6618(95)80052-2

Improvement of Schizophrenic Patients Treated With Des-Tyr1]-γ-endorphin (DTγE)

3 June 2024

12

1 reference

https://api.crossref.org/works/10.1016/1043-6618(95)80052-2

Central catecholamine neuron systems: anatomy and physiology of the dopamine systems

3 June 2024

14

1 reference

https://api.crossref.org/works/10.1016/1043-6618(95)80052-2

3 June 2024

The dopamine connection

15

1 reference

https://api.crossref.org/works/10.1016/1043-6618(95)80052-2

Multiple receptors for dopamine

3 June 2024

16

1 reference

https://api.crossref.org/works/10.1016/1043-6618(95)80052-2

Dopamine receptors in the guinea-pig heart. A binding study

3 June 2024

18

1 reference

https://api.crossref.org/works/10.1016/1043-6618(95)80052-2

Time Course for Effects of Sulpiride and Chlorpromazine on Monoamine Metabolite and Prolactin Levels in Cerebrospinal Fluid from Schizophrenic Patients

3 June 2024

21

1 reference

https://api.crossref.org/works/10.1016/1043-6618(95)80052-2

Dopamine D2 receptors and dopamine metabolism. Relationship between biochemical and behavioural effects of substituted benzamide drugs.

3 June 2024

22

1 reference

https://api.crossref.org/works/10.1016/1043-6618(95)80052-2

N-n-propyl-norapomorphine: an extremely potent stimulant of dopamine autoreceptors

3 June 2024

23

1 reference

https://api.crossref.org/works/10.1016/1043-6618(95)80052-2

Evidence for dopamine receptors in the human brain mediating sedation and sleep

3 June 2024

25

1 reference

https://api.crossref.org/works/10.1016/1043-6618(95)80052-2

Apomorphine hydrochloride-induced improvement in Huntington's chorea: stimulation of dopamine receptor

3 June 2024

26

1 reference

https://api.crossref.org/works/10.1016/1043-6618(95)80052-2

The anti-emetic properties of 1-sulpiride in a ground-based model of space motion sickness.

3 June 2024

30

1 reference

https://api.crossref.org/works/10.1016/1043-6618(95)80052-2

Activation of DA1 receptors by dopamine or fenoldopam increases cyclic AMP levels in the renal artery but not in the superior cervical ganglion of the rat

3 June 2024

32

1 reference

https://api.crossref.org/works/10.1016/1043-6618(95)80052-2

Dopamine produces forearm vasodilatation following alpha-adrenoceptor blockade by an action on vascular dopamine (DA1) receptors in man

3 June 2024

33

1 reference

https://api.crossref.org/works/10.1016/1043-6618(95)80052-2

The action of a dopamine (DA1) receptor agonist, fenoldopam in human vasculature in vivo and in vitro

3 June 2024

34

1 reference

https://api.crossref.org/works/10.1016/1043-6618(95)80052-2

The pharmacokinetics of intravenous and oral sulpiride in healthy human subjects

3 June 2024

41

1 reference

https://api.crossref.org/works/10.1016/1043-6618(95)80052-2

Involvement of central dopamine and D1 receptors in stress-induced colonic motor alterations in rats

3 June 2024

42

1 reference

https://api.crossref.org/works/10.1016/1043-6618(95)80052-2

The effects of S(-) and R(+) sulpiride, metoclopramide, cisapride and domperidone on the small intestine suggest DA2-receptors are involved in the control of small intestinal transit time in rats

3 June 2024

43

1 reference

https://api.crossref.org/works/10.1016/1043-6618(95)80052-2

The effect of dopamine on the overflow of endogenous noradrenaline from the perfused rabbit heart evoked by sympathetic nerve stimulation

3 June 2024

44

1 reference

https://api.crossref.org/works/10.1016/1043-6618(95)80052-2

Effect of sulpiride on ischemia- and reperfusion-induced heart damage, in rats

3 June 2024

48

1 reference

https://api.crossref.org/works/10.1016/1043-6618(95)80052-2

Enhancement of amphetamine anorexia after chronic administration of sulpiride in rats

3 June 2024

49

1 reference

https://api.crossref.org/works/10.1016/1043-6618(95)80052-2

Brain dopamine D-2 receptor mechanisms in spontaneously hypertensive rats

3 June 2024

50

1 reference

https://api.crossref.org/works/10.1016/1043-6618(95)80052-2

Effects of sulpiride and oxypertine on the dopaminergic system in the rat striatum

3 June 2024

51

1 reference

https://api.crossref.org/works/10.1016/1043-6618(95)80052-2

Comparative studies of sulpiride and classical neuroleptics on induction of catalepsy, locomotor activity, and brain dopamine metabolism in mice

3 June 2024

52

1 reference

https://api.crossref.org/works/10.1016/1043-6618(95)80052-2

Changes in dopamine D1, D2 and D3 receptor mRNA levels in rat brain following antipsychotic treatment

3 June 2024

53

1 reference

https://api.crossref.org/works/10.1016/1043-6618(95)80052-2

Differential visualization of dopamine D2 and D3 receptors in rat brain.

3 June 2024

54

1 reference

https://api.crossref.org/works/10.1016/1043-6618(95)80052-2

Prolactin response to low dose sulpiride

3 June 2024

56

1 reference

https://api.crossref.org/works/10.1016/1043-6618(95)80052-2

Effect of substituted benzamides on prolactin secretion in the rat

3 June 2024

57

1 reference

https://api.crossref.org/works/10.1016/1043-6618(95)80052-2

Repeated administration of (−) sulpiride and SCH 23390 differentially up-regulate D-1 and D-2 dopamine receptor function in rat mesostriatal areas but not in cortical-limbic brain regions

3 June 2024

58

1 reference

https://api.crossref.org/works/10.1016/1043-6618(95)80052-2

Simultaneous administration of TRH and sulpiride caused additive but not synergistic PRL responses in normal subjects

3 June 2024

59

1 reference

https://api.crossref.org/works/10.1016/1043-6618(95)80052-2

Neuroendocrine responses to single oral doses of remoxipride and sulpiride in healthy female and male volunteers

3 June 2024

60

1 reference

https://api.crossref.org/works/10.1016/1043-6618(95)80052-2

3 June 2024

Identifiers

1 reference

4 August 2017

1 reference